Innov Clin Neurosci. 2026;23(1–3):17–22. by Kenny Nguyen, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and Eileen Trigoboff, PMHCNS-BC, DNS, DABFN Drs. Nguyen and Demler are with The New York
Innov Clin Neurosci. 2026;23(1–3):27–31. by Vatsala Sharma, MD; Vimala Sim, MD, MBA; and Maria Chona P. San Gabriel, MD, DFAPA All authors are with Department of Psychiatry, Icahn School of
Innov Clin Neurosci. 2026;23(1–3):32–38. by Humphrey Masimba Makumbirofa, MSc; Tariro Tsitsidzashe Hluyo, BPharm; Jonathan Chaweza, BTech; Simbarashe Wandayi, MVPG, BVSc; and Nyarai Desiree Soko, PhD, MSc Messrs. Makumbirofa, Hluyo, Chaweza,
Innov Clin Neurosci. 2026;23(1–3):39–46. by Steven Wickens, MPsych, and Trevor Brown, PhD Both authors are with Neurocare Group, Melbourne, Australia. FUNDING: No funding was provided for this article. DISCLOSURES: The
Innov Clin Neurosci. 2026;23(1–3):47–53. by Hamed Zarei, MD*; Mohammadhossein Vazirizadeh-Mahabadi, MD*; Narges Saadatipour, MD; Maryam Pazhooha, MD; Mostafa Hosseini, PhD; and Mahmoud Yousefifard, PhD *Drs. Zarei and Vazirizadeh-Mahabadi contributed equally
by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:
Innov Clin Neurosci. 2025;22(10–12):14–23. by Samaneh Ghorbani Shirkouhi, MSc; Seyed Sepehr Khatami, MD; Zohair Niroomand, MD; Saeed Sadigh-Eteghad, PhD; Shahrokh Yousefzadeh-Chabok, MD; and Sasan Andalib, PhD Ms. Ghorbani Shirkouhi is
Innov Clin Neurosci. 2025;22(10–12):24–32. by Mark A. Colijn, MD, MSc, FRCPC, UCNS Dr. Colijn is with the Department of Psychiatry, Mathison Centre for Mental Health Research and Education, and Hotchkiss
Innov Clin Neurosci. 2025;22(10–12):33–51. by Franco Di Cesare, MD; Cristiana Di Carlo, MPhil; and Leonardo Di Cesare, MD All authors are with Leoben Research Aurora in San Vincenzo Valle Roveto
Innov Clin Neurosci. 2025;22(10–12):57–71. by Jayant Totlani, DO; Muhammad Arsalan Bashir, MBBS; Laurel Tay, BA; Ashley Ngor, BS; Alexander J. Steiner, PsyD; Drew Hirsch, BS; Lorena Contreras, MA; Sabrina Renteria,
Innov Clin Neurosci. 2025;22(10–12):52–56. by Alexandria Nasr, MD; Larrilyn Grant, MD; Jennifer Golida, BS; and Bailey Hangen, BS, MS All authors are affiliated with the Boonshoft School of Medicine at
Innov Clin Neurosci. 2025;22(10–12):72–77. by Anam Shahid, PhD; Alia Asmat, PhD; and Sunny Singh, MD Dr. Shahid and Dr. Singh are with the Nova Scotia Health Authority in Sydney, Nova
Innov Clin Neurosci. 2025;22(10–12):86–87. by Justin Pope, JD Mr. Pope is Associate Director of Risk Management at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation
Due to the timely nature of this topic, we are providing an advanced release of this article, ahead of the October-December 2025 issue publication. This article is subject to changes
Dear Editor: Although poststroke psychosis is a reasonably well-established clinical phenomenon,1 few articles describing the development of psychotic symptoms on the background of a perinatal stroke history or other anoxic
Dear Editor: I read with interest the article by Allen et al1 about a 19-year-old male transgender patient who developed seizures after intentionally taking 2,000mg of fluoxetine. His medical history
Dear Editor: We thank the author for their thoughtful and insightful comments on our case report.1 We fully agree that fluoxetine has a known potential to trigger seizures, especially in
by Rahi Patel, MD; Amin Ashraf, BS; Nicholas Myers, BS; and Nita Bhatt, MD, MPH Dr. Patel is with Beth Israel Deaconess Medical Center at Harvard Medical School in Boston,
Innov Clin Neurosci. 2025;22(7–9):18–23. by Robert G. Bashuk, MD; Stephen L. Scranton, MD, FACP; Robert S. Allen, AuD, and Marco Cecchi, PhD Drs. Bashuk and Allen are with the Concussion
Gut Microbiota as a Therapeutic Target for Chronic Pain Disorders
Innov Clin Neurosci. 2026;23(1–3):23–26. by Takahiko Nagamine, MD, PhD Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Hofu, Japan. FUNDING: No funding was provided
Read More